Hillstream BioPharma, Inc. Profile Avatar - Palmy Investing

Hillstream BioPharma, Inc.

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's produc…

Biotechnology
US, Bridgewater [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of HILS's Analysis
CIK: 1861657 CUSIP: 432705101 ISIN: US4327051011 LEI: - UEI: -
Secondary Listings
HILS has no secondary listings inside our databases.